M
Mingyue Li
Researcher at Zhejiang University
Publications - 4
Citations - 91
Mingyue Li is an academic researcher from Zhejiang University. The author has contributed to research in topics: Metastasis & Ovarian cancer. The author has an hindex of 3, co-authored 4 publications receiving 22 citations.
Papers
More filters
Journal ArticleDOI
Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis.
TL;DR: It is suggested that microenvironment remodeled by tumor cells and stromal cells promotes fibroblasts to secrete COL1A1 and facilitates the metastasis of ovarian cancer, which may provide a new approach for ovarian cancer therapeutics.
Journal ArticleDOI
LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1.
Conghui Wang,Jiaying Wang,Shen Xiameng,Mingyue Li,Yongfang Yue,Xiaodong Cheng,Weiguo Lu,Xinyu Wang,Xing Xie +8 more
TL;DR: In this article, the authors investigated how long non-coding RNA (lncRNA) SPOCD1-AS from ovarian cancer extracellular vesicles (EVs) remodel mesothelial cells through a mesothel-to-mesenchymal transition (MMT) manner and facilitate peritoneal metastasis.
Journal ArticleDOI
Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer.
Jiaying Wang,Conghui Wang,Yang Li,Mingyue Li,Tingjia Zhu,Zhangjin Shen,Hui Wang,Weiguo Lv,Xinyu Wang,Xiaodong Cheng,Xing Xie +10 more
TL;DR: In this article, the effect and mechanism of exosomal miR-92b-3p from ovarian cancer cells on tumor-associated angiogenesis and the potential of artificially generated exosomes with overexpressed miR92b3p to be used as anti-angiogenic agent was demonstrated.
Journal ArticleDOI
CNN3 acts as a potential oncogene in cervical cancer by affecting RPLP1 mRNA expression
TL;DR: It is verified that CNN3 acts as an oncogene to promote the viability and motility of cervical cancer cells in vitro and accelerate the growth and metastasis of xenografted tumours in vivo, by affecting RPLP1 expression.